Pelthos TherapeuticsPTHS
13F holders, Q4 2025 (December 31)15holders +1
4new positions
3sold out
1famous investor
$31.00avg. 13F price*
At the end of Q4 2025, 15 institutions reported holding Pelthos Therapeutics Inc. (PTHS) in their 13F filings, up 1 from Q3 2025. 4 opened new positions and 3 sold out. The largest holders were Murchinson Ltd. ($9.0M), Ikarian Capital, LLC ($7.9M) and Boothbay Fund Management, LLC ($2.5M). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Pelthos Therapeutics Inc.
- CUSIP
- 171126204
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $4.1M |
| Exits | 3 | $23K |
All 13F filers, Q3 2025 → Q4 2025: 437,426 shares bought and 829 shares sold, net +436,597 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 15 holders
| Murchinson Ltd. | 5.60% | Add +3.4% | 289,479 | $9.0M |
| Ikarian Capital, LLC | 1.03% | Add +309.5% | 255,758 | $7.9M |
| Boothbay Fund Management, LLC | 0.07% | Add +279.8% | 80,680 | $2.5M |
| J. Goldman & Co LP | 0.09% | New | 78,006 | $2.4M |
| Vanguard Group Inc. | 0.00% | Add +12.2% | 75,020 | $2.3M |
| Cantor Fitzgerald, L. P. | 0.03% | New | 34,990 | $1.1M |
| Diadema Partners LP | 0.46% | Add +138.1% | 25,000 | $775K |
| Knott David M Jr | 0.28% | Add +215.5% | 19,281 | $598K |
| Geode Capital Management, LLC | 0.00% | Add +31.9% | 13,625 | $422K |
| Millennium Management | 0.00% | New | 11,057 | $343K |
| Pale Fire Capital SE | 0.03% | New | 8,100 | $251K |
| Persistent Asset Partners Ltd | 0.09% | Add +150.0% | 6,007 | $186K |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 1,910 | $59K |
| UBS Group AG | 0.00% | Add +216.8% | 434 | $13K |
| Bank of America Corp. | 0.00% | Add +9.1% | 12 | $372 |
"% of holder's portfolio" is PTHS's weight in each manager's 13F, not the share of Pelthos Therapeutics Inc. the manager owns.